850
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Morbidity benefit conferred by childhood immunisation in relation to maternal HIV status: a meta-analysis of demographic and health surveys

ORCID Icon, ORCID Icon & ORCID Icon
Pages 2414-2426 | Received 11 Apr 2018, Accepted 18 Aug 2018, Published online: 13 Sep 2018

Figures & data

Table 1. Year of DHS survey and socio-economic characteristics of 27 study countries in sub-Saharan Africa.

Table 2. No of cases and percentages of symptoms of acute respiratory infections and episodes of diarrhoea among the children with respect to DTP3 vaccination in 27 countries in sub-Saharan Africa.

Table 3. No of cases and percentages of symptoms of acute respiratory infections and episodes of diarrhoea among the children with uptake of DTP3 and maternal HIV status in 27 countries in sub-Saharan Africa.

Figure 1. Forest plot showing the prevalence of estimates of symptoms of acute respiratory infections among the children with respect to DTP3 vaccination in 27 sub-Saharan Africa countries.

Figure 1. Forest plot showing the prevalence of estimates of symptoms of acute respiratory infections among the children with respect to DTP3 vaccination in 27 sub-Saharan Africa countries.

Figure 2. Forest plot showing the prevalence of estimates of episodes of diarrhoea among the children with respect to DTP3 vaccination in 27 sub-Saharan Africa countries.

Figure 2. Forest plot showing the prevalence of estimates of episodes of diarrhoea among the children with respect to DTP3 vaccination in 27 sub-Saharan Africa countries.

Figure 3. Forest plot showing the prevalence of estimates of symptoms of acute respiratory infections among the children of HIV-infected mothers with respect to DTP3 vaccination in selected sub-Saharan Africa countries.

Figure 3. Forest plot showing the prevalence of estimates of symptoms of acute respiratory infections among the children of HIV-infected mothers with respect to DTP3 vaccination in selected sub-Saharan Africa countries.

Figure 4. Forest plot showing the prevalence of estimates of episodes of diarrhoea among the children of HIV-infected mothers with respect to DTP3 vaccination in selected sub-Saharan Africa countries.

Figure 4. Forest plot showing the prevalence of estimates of episodes of diarrhoea among the children of HIV-infected mothers with respect to DTP3 vaccination in selected sub-Saharan Africa countries.

Figure 5. Forest plot showing theprevalence of estimates of symptoms of acute respiratory infections among the children who were vaccinated with DTP3 with respect to the maternal HIV status in 27 sub-Saharan Africa countries.

Figure 5. Forest plot showing theprevalence of estimates of symptoms of acute respiratory infections among the children who were vaccinated with DTP3 with respect to the maternal HIV status in 27 sub-Saharan Africa countries.

Figure 6. Forest plot showing the prevalence of estimates of episodes of diarrhoea among the children who were vaccinated with DTP3 with respect to the maternal HIV status in 26 sub-Saharan Africa countries.

Figure 6. Forest plot showing the prevalence of estimates of episodes of diarrhoea among the children who were vaccinated with DTP3 with respect to the maternal HIV status in 26 sub-Saharan Africa countries.

Figure 7. A plot showing the influence of each country on the overall pooled result for estimates of acute respiratory infections using “leave-one-country-out” sensitivity analysis.

Figure 7. A plot showing the influence of each country on the overall pooled result for estimates of acute respiratory infections using “leave-one-country-out” sensitivity analysis.

Figure 8. A plot showing the influence of each country on the overall pooled result for estimates of diarrhoea using “leave-one-country-out” sensitivity analysis.

Figure 8. A plot showing the influence of each country on the overall pooled result for estimates of diarrhoea using “leave-one-country-out” sensitivity analysis.

Table 4. Subgroup analysis and univariate meta-regression analysis results (for diarrhoea).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.